2017/2018
Scheduled market launch in USA, Australia, Brazil
–
CE mark approval permamem® scheduled
2016
Third bone & tissue days in Berlin
–
Pre-launch of first products in the USA
–
Straumann takes over exclusive distribution of botiss products in Germany
2015
Market launch of maxgraft® cortico
–
botiss participation at 8 ITI congresses worldwide
2014
Pharmaceutical approval for maxgraft® and for maxgraft® bonebuilder
–
Second bone & tissue days in Berlin with 800 participants
–
Worldwide cooperation with Straumann in the field of regenerative products
2013
Exclusive cooperation with the Charité tissue bank for the dental regeneration
2012
First bone & tissue days in Berlin
2011
CE mark approval for mucoderm® and for maxresorb® inject
–
Acquisition of Cells+Tissubank Austria
2010
CE mark approval for collprotect® membrane
2009
CE mark approcal for Jason® membrane
2008
Establishment of botiss medical AG
2007
CE mark approval for maxresorb®
2002
CE mark approval for cerabone®, employed since 2006 in the dental field